|
Jim Loughlin was named to the Celgene Board of Directors in January 2007 and serves as a member of the Audit Committee. Mr.. Loughlin an experienced corporate director served as the National Director of the Pharmaceuticals Practice at KPMG including a five-year term as member of the Board of Directors of KPMG LLP. Additionally Mr.. Loughlin served as Chairman of the Pension and Investment Committee of the KPMG Board from 1995 through 2001. He also served as Partner in charge of Human Resources Chairman of the Personnel and Professional Development Committee Secretary and Trustee of the Peat Marwick Foundation and a member of the Pension Operating and Strategic Planning Committees. | 